Alnylam Pharmaceuticals (ALNY) Construction in Progress (2012 - 2018)

Alnylam Pharmaceuticals has reported Construction in Progress for 7 years, with the latest figure at $261.0 million in Q4 2018.

• For the quarter ending Q4 2018, Construction in Progress rose 95.27% year-over-year to $261.0 million; the trailing twelve-month figure through Dec 2018 stood at $261.0 million (up 95.27% YoY), and the FY2018 full-year result was $261.0 million, up 95.27% from the prior year.
• Construction in Progress for Q4 2018 stood at $261.0 million, up from $133.6 million in the prior quarter.
• The five-year high for Construction in Progress was $261.0 million in Q4 2018, with the low at $1.3 million in Q4 2015.
• Historically, Construction in Progress has averaged $93.2 million across 5 years, with a median of $68.2 million in 2016.
• Annual changes were most pronounced in 2014 — Construction in Progress jumped 6978.57% — and 2015, when it plunged 35.17%.
• Alnylam Pharmaceuticals' Construction in Progress stood at $2.0 million in 2014, then sank by 35.17% to $1.3 million in 2015, then jumped by 5205.99% to $68.2 million in 2016, then surged by 96.01% to $133.6 million in 2017, then soared by 95.27% to $261.0 million in 2018.
• The last three Construction in Progress figures came in at $261.0 million (Q4 2018), $133.6 million (Q4 2017), and $68.2 million (Q4 2016), per Business Quant data.